BioCode SARS-CoV-2 Assay
COVID-19
CommercialActive
Key Facts
About Applied BioCode
Applied BioCode is a private, commercial-stage diagnostics company specializing in multiplex syndromic panel testing for infectious diseases. Its proprietary BioCode platform, centered on barcoded magnetic beads, enables high-throughput, cost-effective detection of multiple pathogens on its MDx-3000 instrument system. The company has an FDA-cleared gastrointestinal panel and a portfolio of research-use and development-stage panels for respiratory, fungal, and sexually transmitted infections, positioning it in the growing multiplex molecular diagnostics market. Its value proposition emphasizes operational efficiency, flexibility in test ordering, and maximizing insurance reimbursement.
View full company profileTherapeutic Areas
Other COVID-19 Drugs
| Drug | Company | Phase |
|---|---|---|
| COVID-19 Severity Prediction Test | Age Labs | Development |
| PanCytoVir™ (oral probenecid) | TrippBio | Phase 2 |
| ARCoV | Abogen | Approved (EUA) |
| OT-101 | Sapu BioScience | Clinical Trial (Phase not specified) |
| COVID-19 Vaccine (Inactivated) | Kangtai Biological Products | Approved |
| COVID-19 Vaccine (Adenovirus Vector) | Kangtai Biological Products | Approved |
| Idylla SARS-CoV-2 Test | Biocartis | Approved |
| Adjuvanted Cell-Based COVID-19 Vaccine | CSL Seqirus | Marketed |
| Sequential Dialysis Technique | Halberd | Discovery |
| Amubarvimab + Romlusevimab (BRII-196/BRII-198) | Brii Biosciences | Approved |
| COVID-19 Vaccine Testing (for AstraZeneca) | Advaxia Biologics | Approved |
| COVID-19 Vaccine Clinical Batches | Advaxia Biologics | Clinical |